# |
Searches |
1 |
exp ERYTHROPOIETIN/ |
2 |
exp ERYTHROPOIETIN, RECOMBINANT/ |
3 |
erythropoietin.mp. |
4 |
erythropoiesis.mp. |
5 |
exp EPOETIN ALFA/ |
6 |
epoetin.mp. |
7 |
epo.mp. |
8 |
epoetin alfa.mp. |
9 |
epoetin beta.mp. |
10 |
eprex.mp. |
11 |
neorecormon.mp. |
12 |
aranesp.mp. |
13 |
procrit.mp. |
14 |
recombinant erythropoietin.mp. |
15 |
darbepoetin alfa.mp. |
16 |
darbepoetin.mp. |
17 |
RECEPTORS, ERYTHROPOIETIN/ |
18 |
CERA.mp. |
19 |
or/1‐18 |
20 |
anaemia.mp. |
21 |
anemia.mp. |
22 |
(anemi$ adj3 cancer).mp. |
23 |
(anaemi$ adj3 cancer).mp. |
24 |
or/20‐23 |
25 |
Anemia, Iron‐Deficiency/ |
26 |
Iron/ |
27 |
Iron Compounds/ |
28 |
iron*.sh. |
29 |
iron*.tw,kf,ot. |
30 |
ferri*.tw,kf,ot. |
31 |
(ferro* adj2 (compound* or compund*)).tw,kf,ot. |
32 |
hemosider*.tw,kf,ot. |
33 |
sideros*.tw,kf,ot. |
34 |
transferrin*.tw,kf,ot. |
35 |
or/25‐34 |
36 |
19 and 24 |
37 |
19 and 24 and 35 |
38 |
exp Neoplasms/ |
39 |
malignan$.mp. |
40 |
cancer$.mp. |
41 |
oncolog$.tw. |
42 |
myelodysplas$.tw. |
43 |
chemotherapy.mp. |
44 |
tumo?r$.mp. |
45 |
carcinom$.mp. |
46 |
or/38‐45 |
47 |
exp Antineoplastic Agents/ |
48 |
Remission Induction/ |
49 |
exp antineoplastic protocols/ |
50 |
((consolidat$ or induct$ or maintenance or conditioning$) and (therap$ or treat$ or regimen$ or patient$)).tw,kf,ot. |
51 |
((anticancer$ or cancer$) adj2 (therap$ or treat$)).tw,kf,ot. |
52 |
(remission$ adj2 therap$).tw,kf,ot. |
53 |
(remission$ adj2 induction$).tw,kf,ot. |
54 |
(chemotherap$ or chemo‐therap$).tw,kf,ot. |
55 |
(Antineoplast$ or anti‐neoplast$).tw,kf,ot. |
56 |
((cytosta$ or cytotox$) adj2 (therap$ or treat$ or regimen$)).tw,kf,ot. |
57 |
or/47‐56 |
58 |
37 and 46 |
59 |
37 and 57 |
60 |
58 or 59 |
61 |
randomized controlled trial.pt. |
62 |
controlled clinical trial.pt. |
63 |
randomized.ab. |
64 |
placebo.ab. |
65 |
drug therapy.fs. |
66 |
randomly.ab. |
67 |
trial.ab. |
68 |
groups.ab. |
69 |
or/61‐68 |
70 |
humans.sh. |
71 |
69 and 70 |
72 |
60 and 71 |
73 |
from 72 keep 1‐542 |